Therapy Areas: Autoimmune
21 September 2023 - Kyverna Therapeutics, a California-based clinical-stage cell therapy company, announced on Wednesday that it has signed a non-exclusive, multi-year license and supply agreement wit...
21 September 2023 - Everest Medicines (HKEX 1952.HK), a China-based biopharmaceutical company, announced on Wednesday that it has signed a collaboration and license agreement with Kezar Life Sciences,...
19 September 2023 - Biopharmaceutical company Pfizer Inc (NYSE: PFE) announced on Tuesday that it has received European Commission (EC) marketing authorisation for LITFULO (ritlecitinib) to treat seve...
14 September 2023 - Q32 Bio, a clinical stage biotechnology company, and Horizon Therapeutics plc (Nasdaq: HZNP), a biopharmaceutical company, announced on Wednesday that the first subject has been do...
6 September 2023 - Swedish biotechnology company Cantargia AB (STO:CANTA) said on Wednesday that it has received Orphan Drug Designation from the US Food and Drug Administration (FDA) for CAN10 in the...
5 September 2023 - Immunotherapy company Alpine Immune Sciences (NASDAQ: ALPN)announced on Tuesday that it will present new preclinical data on povetacicept for myasthenia gravis at the 148th Annual A...